We have previously reported that decreased ATF3 expression is correlated with poor differentiation and shorter overall survival in PAAD patients, indicating that ATF3 is essential to the progression of pancreatic cancer (14). This evidence concerns the gene ATF3 and familial pancreatic carcinoma.